CEL-SCI logo

CVM - CEL-SCI News Story

$6.17 0.5  9.4%

Last Trade - 9:10pm

Sector
Healthcare
Size
Small Cap
Market Cap £179.9m
Enterprise Value £159.0m
Revenue £n/a
Position in Universe 4546th / 7405

BRIEF-CEL-SCI submits response to FDA in connection with partial clinical hold on phase 3 clinical trial

Mon 21st November, 2016 1:30pm
Nov 21 (Reuters) - Cel-sci Corp  CVM.A : 
    * CEL-SCI Corp - submitted response to FDA regarding partial 
clinical hold of CEL-SCI's phase 3 clinical trial of its 
investigational drug multikine 
    * CEL-SCI submits response to fda in connection with partial 
clinical hold on phase 3 clinical trial 
 
Source text for Eikon:  ID:nBw2xBtlBa  
Further company coverage:  CVM.A  
 
 ((bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.